Sun Pharma's biggest-ever $11.75bn Organon & Co. deal lifts markets

Experts warn on oil and geopolitics

Sun Pharma's move is a major win for India's pharma scene and has lifted the mood across related stocks.
But experts such as Vinod Nair are still keeping an eye on global issues, such as rising oil prices and ongoing geopolitical tensions that could make markets jumpy.
His advice: stay alert to these trends, but for now, things look positive as long as crude prices do not spike.